269 related articles for article (PubMed ID: 30131066)
21. Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice.
Meregalli C; Carozzi VA; Sala B; Chiorazzi A; Canta A; Oggioni N; Rodriguez-Menendez V; Ballarini E; Ceresa C; Nicolini G; Crippa L; Orciani M; Cavaletti G; Marmiroli P
J Biol Regul Homeost Agents; 2015; 29(1):115-24. PubMed ID: 25864747
[TBL] [Abstract][Full Text] [Related]
22. Effect of lumbar 5 ventral root transection on pain behaviors: a novel rat model for neuropathic pain without axotomy of primary sensory neurons.
Li L; Xian CJ; Zhong JH; Zhou XF
Exp Neurol; 2002 May; 175(1):23-34. PubMed ID: 12009757
[TBL] [Abstract][Full Text] [Related]
23. Neuropathic Pain and Nerve Growth Factor in Chemotherapy-Induced Peripheral Neuropathy: Prospective Clinical-Pathological Study.
Velasco R; Navarro X; Gil-Gil M; Herrando-Grabulosa M; Calls A; Bruna J
J Pain Symptom Manage; 2017 Dec; 54(6):815-825. PubMed ID: 28797868
[TBL] [Abstract][Full Text] [Related]
24. Pathological adaptive responses of Schwann cells to endoplasmic reticulum stress in bortezomib-induced peripheral neuropathy.
Shin YK; Jang SY; Lee HK; Jung J; Suh DJ; Seo SY; Park HT
Glia; 2010 Dec; 58(16):1961-76. PubMed ID: 20830808
[TBL] [Abstract][Full Text] [Related]
25. Kinesin-5 Blocker Monastrol Protects Against Bortezomib-Induced Peripheral Neurotoxicity.
Bobylev I; Peters D; Vyas M; Barham M; Klein I; von Strandmann EP; Neiss WF; Lehmann HC
Neurotox Res; 2017 Nov; 32(4):555-562. PubMed ID: 28612296
[TBL] [Abstract][Full Text] [Related]
26. Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN).
Han Y; Smith MT
Front Pharmacol; 2013 Dec; 4():156. PubMed ID: 24385965
[TBL] [Abstract][Full Text] [Related]
27. Spinal administration of mGluR5 antagonist prevents the onset of bortezomib induced neuropathic pain in rat.
Ghelardini C; Menicacci C; Cerretani D; Bianchi E
Neuropharmacology; 2014 Nov; 86():294-300. PubMed ID: 25128849
[TBL] [Abstract][Full Text] [Related]
28. Effects of progesterone on neuropathic pain responses in an experimental animal model for peripheral neuropathy in the rat: a behavioral and electrophysiological study.
Jarahi M; Sheibani V; Safakhah HA; Torkmandi H; Rashidy-Pour A
Neuroscience; 2014 Jan; 256():403-11. PubMed ID: 24184116
[TBL] [Abstract][Full Text] [Related]
29. Walnut consumption protects rats against cisplatin-induced neurotoxicity.
Shabani M; Nazeri M; Parsania S; Razavinasab M; Zangiabadi N; Esmaeilpour K; Abareghi F
Neurotoxicology; 2012 Oct; 33(5):1314-21. PubMed ID: 22935099
[TBL] [Abstract][Full Text] [Related]
30. Role of Complement in a Rat Model of Paclitaxel-Induced Peripheral Neuropathy.
Xu J; Zhang L; Xie M; Li Y; Huang P; Saunders TL; Fox DA; Rosenquist R; Lin F
J Immunol; 2018 Jun; 200(12):4094-4101. PubMed ID: 29695418
[TBL] [Abstract][Full Text] [Related]
31. Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy.
Lees JG; Makker PG; Tonkin RS; Abdulla M; Park SB; Goldstein D; Moalem-Taylor G
Eur J Cancer; 2017 Mar; 73():22-29. PubMed ID: 28104535
[TBL] [Abstract][Full Text] [Related]
32. Current understanding of the molecular mechanisms of chemotherapy-induced peripheral neuropathy.
Chen X; Gan Y; Au NPB; Ma CHE
Front Mol Neurosci; 2024; 17():1345811. PubMed ID: 38660386
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapy-induced peripheral neurotoxicity.
Cavaletti G; Marmiroli P
Curr Opin Neurol; 2015 Oct; 28(5):500-7. PubMed ID: 26197027
[TBL] [Abstract][Full Text] [Related]
34. Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity.
Canta A; Chiorazzi A; Pozzi E; Fumagalli G; Monza L; Meregalli C; Carozzi VA; Rodriguez-Menendez V; Oggioni N; Näsström J; Marmiroli P; Cavaletti G
Antioxidants (Basel); 2020 Jul; 9(7):. PubMed ID: 32645985
[TBL] [Abstract][Full Text] [Related]
35. Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat.
Cavaletti G; Gilardini A; Canta A; Rigamonti L; Rodriguez-Menendez V; Ceresa C; Marmiroli P; Bossi M; Oggioni N; D'Incalci M; De Coster R
Exp Neurol; 2007 Mar; 204(1):317-25. PubMed ID: 17214983
[TBL] [Abstract][Full Text] [Related]
36. Chemotherapy-induced neuropathy: A comprehensive survey.
Miltenburg NC; Boogerd W
Cancer Treat Rev; 2014 Aug; 40(7):872-82. PubMed ID: 24830939
[TBL] [Abstract][Full Text] [Related]
37. The neuroprotective effect of tropisetron on vincristine-induced neurotoxicity.
Barzegar-Fallah A; Alimoradi H; Mehrzadi S; Barzegar-Fallah N; Zendedel A; Abbasi A; Dehpour AR
Neurotoxicology; 2014 Mar; 41():1-8. PubMed ID: 24374478
[TBL] [Abstract][Full Text] [Related]
38. Ameliorative potential of ferulic acid in vincristine-induced painful neuropathy in rats: An evidence of behavioral and biochemical examination.
Vashistha B; Sharma A; Jain V
Nutr Neurosci; 2017 Jan; 20(1):60-70. PubMed ID: 25494651
[TBL] [Abstract][Full Text] [Related]
39. Antibody against tumor necrosis factor-α reduces bortezomib-induced allodynia in a rat model.
Chiorazzi A; Canta A; Meregalli C; Carozzi V; Sala B; Oggioni N; Monbaliu J; VAN DE Velde H; Cavaletti G
Anticancer Res; 2013 Dec; 33(12):5453-9. PubMed ID: 24324081
[TBL] [Abstract][Full Text] [Related]
40. Comparison of sensory tests and neuronal quantity of peripheral nerves between streptozotocin (STZ)-induced diabetic rats and paclitaxel (PAC)-treated rats.
Jin HY; Lee NY; Ko HA; Lee KA; Park TS
Somatosens Mot Res; 2016; 33(3-4):186-195. PubMed ID: 27756190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
